$377 Million is the total value of Ghost Tree Capital, LLC's 49 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 67.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Buy | SPDR SER TRput | $57,112,000 | +20.1% | 737,500 | +47.5% | 15.15% | +67.3% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $37,812,000 | -41.3% | 146,700 | -26.6% | 10.03% | -18.2% |
| QQQ | New | INVESCO QQQ TRput | $33,168,000 | – | 174,200 | +100.0% | 8.80% | – |
| XLV | New | SELECT SECTOR SPDR TRcall | $21,676,000 | – | 244,700 | +100.0% | 5.75% | – |
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $20,430,000 | -24.6% | 650,000 | +12.9% | 5.42% | +5.0% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $16,892,000 | -39.3% | 150,000 | -25.0% | 4.48% | -15.5% |
| IMMU | Buy | IMMUNOMEDICS INC | $14,154,000 | +33.8% | 1,050,000 | +110.0% | 3.75% | +86.3% |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $12,755,000 | -5.8% | 1,305,500 | +11.1% | 3.38% | +31.2% |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $12,648,000 | -38.8% | 215,000 | +7.5% | 3.36% | -14.8% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $11,660,000 | +154.4% | 2,000,000 | +150.0% | 3.09% | +254.3% |
| IMVT | Sell | IMMUNOVANT INC | $11,051,000 | -13.0% | 710,000 | -11.2% | 2.93% | +21.2% |
| MNTA | MOMENTA PHARMACEUTICALS INC | $10,880,000 | +37.9% | 400,000 | 0.0% | 2.89% | +92.0% | |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $10,477,000 | -41.8% | 350,000 | -46.2% | 2.78% | -18.9% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $9,068,000 | -43.1% | 650,000 | -7.1% | 2.40% | -20.7% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $8,840,000 | -54.3% | 115,000 | -23.3% | 2.34% | -36.3% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $7,217,000 | -52.9% | 50,000 | -33.3% | 1.91% | -34.5% |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $5,804,000 | -52.3% | 400,000 | -33.3% | 1.54% | -33.5% |
| FATE | Sell | FATE THERAPEUTICS INC | $4,997,000 | -7.2% | 225,000 | -18.2% | 1.32% | +29.3% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $4,417,000 | -36.8% | 585,000 | +30.0% | 1.17% | -11.9% |
| SELB | Buy | SELECTA BIOSCIENCES INC | $4,157,000 | +51.9% | 1,725,000 | +50.0% | 1.10% | +111.7% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $4,000,000 | -61.4% | 2,000,000 | -33.3% | 1.06% | -46.2% |
| VSTM | New | VERASTEM INC | $3,960,000 | – | 1,500,000 | +100.0% | 1.05% | – |
| ZGNX | New | ZOGENIX INC | $3,710,000 | – | 150,000 | +100.0% | 0.98% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $3,686,000 | – | 325,000 | +100.0% | 0.98% | – |
| New | TRILLIUM THERAPEUTICS INC | $3,333,000 | – | 825,000 | +100.0% | 0.88% | – | |
| ARVN | Sell | ARVINAS INC | $3,224,000 | -65.1% | 80,000 | -64.4% | 0.86% | -51.4% |
| FIXX | New | HOMOLOGY MEDICINES INC | $3,108,000 | – | 200,000 | +100.0% | 0.82% | – |
| ISEE | Buy | IVERIC BIO INC | $2,850,000 | -55.7% | 828,459 | +10.5% | 0.76% | -38.3% |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $2,779,000 | – | 350,000 | +100.0% | 0.74% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $2,743,000 | – | 250,000 | +100.0% | 0.73% | – |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $2,678,000 | -63.8% | 350,000 | -15.7% | 0.71% | -49.6% |
| STSA | New | SATSUMA PHARMACEUTICALS INC | $2,475,000 | – | 115,000 | +100.0% | 0.66% | – |
| CHRS | Sell | COHERUS BIOSCIENCES INC | $2,433,000 | -68.6% | 150,000 | -65.1% | 0.64% | -56.2% |
| FXE | New | INVESCO CURRENCYSHARES EURO | $2,173,000 | – | 20,830 | +100.0% | 0.58% | – |
| TGTX | Buy | TG THERAPEUTICS INC | $1,968,000 | +181.5% | 200,000 | +217.5% | 0.52% | +292.5% |
| VRAY | Sell | VIEWRAY INC | $1,957,000 | -61.4% | 782,928 | -34.8% | 0.52% | -46.2% |
| SAGE | New | SAGE THERAPEUTICS INC | $1,867,000 | – | 65,000 | +100.0% | 0.50% | – |
| CUE | New | CUE BIOPHARMA INC | $1,774,000 | – | 125,000 | +100.0% | 0.47% | – |
| KNSA | Sell | KINIKSA PHARMACEUTICALS LTD | $1,745,000 | -54.9% | 112,695 | -67.8% | 0.46% | -37.2% |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $1,645,000 | -40.2% | 497,074 | +10.5% | 0.44% | -16.8% |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $1,608,000 | -17.1% | 227,827 | -17.2% | 0.43% | +15.4% |
| KDMN | Sell | KADMON HLDGS INC | $1,467,000 | -30.0% | 350,000 | -24.3% | 0.39% | -2.5% |
| ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $1,341,000 | -56.5% | 178,109 | -20.6% | 0.36% | -39.4% |
| AGTC | New | APPLIED GENETIC TECHNOL CORP | $1,223,000 | – | 372,806 | +100.0% | 0.32% | – |
| BIIB | New | BIOGEN INC | $1,028,000 | – | 3,250 | +100.0% | 0.27% | – |
| AMRN | Sell | AMARIN CORP PLCcall | $662,000 | -87.6% | 165,600 | -33.8% | 0.18% | -82.8% |
| MIST | Sell | MILESTONE PHARMACEUTICALS IN | $384,000 | -89.8% | 208,733 | -11.2% | 0.10% | -85.8% |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -38,340 | -100.0% | -0.03% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -11,500 | -100.0% | -0.04% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -50,500 | -100.0% | -0.18% | – |
| FXB | Exit | INVESCO CURNCYSHS BRIT PND Sbrit poun strl | $0 | – | -11,600 | -100.0% | -0.28% | – |
| CHMA | Exit | CHIASMA INC | $0 | – | -425,000 | -100.0% | -0.40% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -40,000 | -100.0% | -0.42% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -33,400 | -100.0% | -0.51% | – |
| INSM | Exit | INSMED INC | $0 | – | -200,000 | -100.0% | -0.91% | – |
| FXF | Exit | INVESCO CURNCYSHS SWISS FRANswiss franc | $0 | – | -52,000 | -100.0% | -0.94% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -175,000 | -100.0% | -1.02% | – |
| ARQL | Exit | ARQULE INC | $0 | – | -300,000 | -100.0% | -1.14% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INCcall | $0 | – | -250,000 | -100.0% | -1.46% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -750,000 | -100.0% | -1.53% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -65,000 | -100.0% | -1.60% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INCput | $0 | – | -300,000 | -100.0% | -1.75% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INCcall | $0 | – | -350,000 | -100.0% | -1.84% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCcall | $0 | – | -150,000 | -100.0% | -2.06% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -150,000 | -100.0% | -2.29% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -1,250,000 | -100.0% | -2.32% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -575,000 | -100.0% | -2.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.